Concord Medical Services Holdings Limited (CCM) |
| 4.83 -0.07 (-1.43%) 05-29 15:59 |
| Open: | 5.18 |
| High: | 5.52 |
| Low: | 4.83 |
| Volume: | 7,830 |
| Market Cap: | 1(M) |
| PE Ratio: | -1.54 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Care Facilities |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 6.80 |
| Resistance 1: | 5.62 |
| Pivot price: | 5.07 |
| Support 1: | 3.71 |
| Support 2: | 3.09 |
| 52w High: | 10.77 |
| 52w Low: | 3.18 |
Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in two segments, Network and Hospital. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. The company's other treatments and diagnostic services comprise computed tomography scanners. In addition, it provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, the company offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, it operates specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2021, it operated a network of 16 cooperative centers based in 13 hospitals. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
| EPS | -3.140 |
| Book Value | -71.390 |
| PEG Ratio | 0.56 |
| Gross Profit | 9.156 |
| Profit Margin (%) | -20.15 |
| Operating Margin (%) | -36.43 |
| Return on Assets (ttm) | -2.3 |
| Return on Equity (ttm) | -21.9 |
Mon, 18 May 2026
Concord Medical announces board changes at Concord Healthcare subsidiary - Investing.com
Wed, 13 May 2026
Concord Medical’s Hong Kong Subsidiary Reshapes Board Leadership After AGM - TipRanks
Wed, 13 May 2026
Concord Healthcare issues HK$68 million in 2% convertible bonds due 2027 - Investing.com
Wed, 29 Apr 2026
Concord Medical Files Annual Report on Form 20-F for the Fiscal Year 2025 - Barchart.com
Tue, 03 Jun 2025
Concord Healthcare Unveils China’s First Proton Therapy-Focused Large Language Model - BioPharma APAC
Tue, 17 Sep 2024
Concord Medical's Guangzhou Cancer Center Secures License for Proton Therapy Equipment - BioPharma APAC
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |